<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04246931</url>
  </required_header>
  <id_info>
    <org_study_id>Chiesi_NIS_0003</org_study_id>
    <nct_id>NCT04246931</nct_id>
  </id_info>
  <brief_title>Adherence Evaluation in COPD</brief_title>
  <official_title>Evaluation of Perception and Knowledge of Adherence to COPD Inhalation Therapy at Patient, GP and Pulmonologist Level</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiesi SA/NV</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiesi SA/NV</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rationale of this study is to have a better understanding of the perception of the
      pulmonologists, general practitioners and patients of adherence (causes, main consequences,
      supportive tools,..) and the use of TAI-questionnaire (appreciation, usability,â€¦) by
      interviewing pulmonologists &amp; general practitioners and a survey with patients. Based on the
      outcome, projects and tools can be developed to help health care professionals to motivate
      patients to improve adherence and to help patients to increase their adherence to inhalation
      therapy.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Knowledge and perception of adherence</measure>
    <time_frame>Baseline</time_frame>
    <description>Gathering knowledge based on semi-structured interview (definition, causes, consequences of bad adherence,...)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Test of the adherence to inhalers-questionnaire (TAI)</measure>
    <time_frame>Baseline</time_frame>
    <description>Evaluate the usability of 'Test of the adherence to inhalers'-questionnaire (TAI) based on semi-structured interview</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Adherence, Treatment</condition>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Pulmonologists</arm_group_label>
    <description>Interviews with pulmonologists</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General practitioners</arm_group_label>
    <description>Interviews with general practitioners</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Survey with COPD patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention (survey)</intervention_name>
    <description>No intervention -&gt; survey at 1 timepoint</description>
    <arm_group_label>General practitioners</arm_group_label>
    <arm_group_label>Patients</arm_group_label>
    <arm_group_label>Pulmonologists</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pulmonologists, general practicioners and COPD patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Pulmonologists or general practitioners or COPD patient (suffering from COPD treated with
        inhalation therapy)

        Exclusion Criteria:

        Not applicable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Sofie Geelissen, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Chiesi Belgium</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medistrat</name>
      <address>
        <city>Lasne</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 15, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2020</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

